![](/img/cover-not-exists.png)
C54CompLEEment-1: phase 3b study of ribociclib + letrozole for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) in patients with no prior endocrine therapy (ET) for ABC
Zamagni, C, Martin, M, Ring, A, Cottu, P, Zhou, K, Wu, J, Zarate, J P, De Laurentiis, MVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx424.053
Date:
October, 2017
File:
PDF, 65 KB
english, 2017